Three-dimensional conformal radiotherapy plus concurrent DICE chemotherapy for early-stage nasal-type natural killer/T-cell lymphoma of Waldeyer's ring: A single-institution study

Objective Nasal-type natural killer/T-cell lymphoma of Waldeyer's ring (WR-NK/TL) has different clinico- pathological characteristics from those of other subtypes of NK/T lymphoma; thus, the optimal treatment remains unclear. To find a more effective treatment model for WR-NK/TL, we conducted a sing...

Full description

Saved in:
Bibliographic Details
Published in肿瘤学与转化医学(英文) Vol. 1; no. 4; pp. 181 - 185
Main Author Ji Zhou Daiyuan Ma Yeqin Zhou Xianfu Li Bangxian Tan Mi Liu Tao Ren
Format Journal Article
LanguageChinese
Published 2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective Nasal-type natural killer/T-cell lymphoma of Waldeyer's ring (WR-NK/TL) has different clinico- pathological characteristics from those of other subtypes of NK/T lymphoma; thus, the optimal treatment remains unclear. To find a more effective treatment model for WR-NK/TL, we conducted a single-center study of concurrent radiochemotherapy. Methods Forty-five patients with newly diagnosed stage IE to liE WR-NKTL were randomly divided into two groups. The 23 cases in the concurrent radiochemotherapy group were treated with three-dimensional conformal radiotherapy (48-52 Gy) and 2 courses of DICE (dexamethasone, ifosfamide, cisplatin, and etoposide) synchronous chemotherapy. The 22 cases in the radiotherapy group only received three-dimen- sional conformal radiotherapy (50-54 Gy). The primary end points were overall survival (OS), progression- free survival (PFS), and toxicity. Results The 1-, 3-, and 4-year OS and PFS rates were 95.5%, 65.6%, and 45.9%, and 86.4%, 56.0%, and 46.7% in the radiotherapy gro
Bibliography:nasal cavity; NK/T-cell lymphoma; prognosis; radiotherapy; chemotherapy
42-1865/R
Objective Nasal-type natural killer/T-cell lymphoma of Waldeyer's ring (WR-NK/TL) has different clinico- pathological characteristics from those of other subtypes of NK/T lymphoma; thus, the optimal treatment remains unclear. To find a more effective treatment model for WR-NK/TL, we conducted a single-center study of concurrent radiochemotherapy. Methods Forty-five patients with newly diagnosed stage IE to liE WR-NKTL were randomly divided into two groups. The 23 cases in the concurrent radiochemotherapy group were treated with three-dimensional conformal radiotherapy (48-52 Gy) and 2 courses of DICE (dexamethasone, ifosfamide, cisplatin, and etoposide) synchronous chemotherapy. The 22 cases in the radiotherapy group only received three-dimen- sional conformal radiotherapy (50-54 Gy). The primary end points were overall survival (OS), progression- free survival (PFS), and toxicity. Results The 1-, 3-, and 4-year OS and PFS rates w
ISSN:2095-9621
2995-5858